Clinical Trial Update: A Pilot Efficacy and Safety Study of ST101 in Essential Tremor [Phase 2]

View source ↗

Summary

Phase 2 pilot study of ST101 for essential tremor has completed, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• ST101 (ST101)

Snippet

Sponsor: Sonexa Therapeutics, Inc. | Conditions: Essential Tremor | Phase 2 | Status: COMPLETED